Accolade, Inc.

Accolade, Inc. (ACCD) priced its initial public offering on Jul 2, 2020 at $22.00 per share, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $1.04B. Goldman Sachs was lead-left underwriter, joined by Morgan Stanley, BofA Securities and Piper Sandler and others. Cooley advised the company and Paul Hastings advised the underwriters.

Accolade, Inc. provides technology-enabled services that help people understand and use the healthcare system and their workplace benefits. Its customers are mainly employers, and members get support from Health Assistants and clinicians such as nurses, physician medical directors and behavioral health specialists through a cloud-based platform.

Status

IPO

Ticker

ACCD

Exchange

Nasdaq Global Select

Priced

Jul 2, 2020

IPO price

$22.00

Market cap at IPO price

$1.04B

First filed

Feb 28, 2020

Underwriters

Goldman Sachs, Morgan Stanley, BofA Securities, Piper Sandler, Credit Suisse, William Blair, Baird and Leerink Partners

Company counsel

Cooley

Underwriters' counsel

Paul Hastings

Sector

Business services

Country / state

PA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.